210 related articles for article (PubMed ID: 34205996)
1. Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells.
Luo J; Odaka Y; Huang Z; Cheng B; Liu W; Li L; Shang C; Zhang C; Wu Y; Luo Y; Yang S; Houghton PJ; Guo X; Huang S
Cells; 2021 Jun; 10(6):. PubMed ID: 34205996
[TBL] [Abstract][Full Text] [Related]
2. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
3. Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
Beevers CS; Chen L; Liu L; Luo Y; Webster NJ; Huang S
Cancer Res; 2009 Feb; 69(3):1000-8. PubMed ID: 19176385
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells.
Odaka Y; Xu B; Luo Y; Shen T; Shang C; Wu Y; Zhou H; Huang S
Carcinogenesis; 2014 Jan; 35(1):192-200. PubMed ID: 23929438
[TBL] [Abstract][Full Text] [Related]
5. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
6. Electroconvulsive seizure inhibits the mTOR signaling pathway via AMPK in the rat frontal cortex.
Kim SH; Yu HS; Huh S; Kang UG; Kim YS
Psychopharmacology (Berl); 2022 Feb; 239(2):443-454. PubMed ID: 34716784
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
8. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
9. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.
Barroso-Chinea P; Luis-Ravelo D; Fumagallo-Reading F; Castro-Hernandez J; Salas-Hernandez J; Rodriguez-Nuñez J; Febles-Casquero A; Cruz-Muros I; Afonso-Oramas D; Abreu-Gonzalez P; Moratalla R; Millan MJ; Gonzalez-Hernandez T
Autophagy; 2020 Jul; 16(7):1279-1295. PubMed ID: 31538542
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
Agarwal S; Bell CM; Rothbart SB; Moran RG
J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
[TBL] [Abstract][Full Text] [Related]
11. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
12. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
13. ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells.
Sohretoglu D; Zhang C; Luo J; Huang S
Signal Transduct Target Ther; 2019; 4():21. PubMed ID: 31637001
[No Abstract] [Full Text] [Related]
14. Knockdown of MAGEA6 Activates AMP-Activated Protein Kinase (AMPK) Signaling to Inhibit Human Renal Cell Carcinoma Cells.
Ye X; Xie J; Huang H; Deng Z
Cell Physiol Biochem; 2018; 45(3):1205-1218. PubMed ID: 29448247
[TBL] [Abstract][Full Text] [Related]
15. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction.
Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH
J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721
[TBL] [Abstract][Full Text] [Related]
16. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway.
Tamaddoni A; Mohammadi E; Sedaghat F; Qujeq D; As'Habi A
Pharmacol Res; 2020 Jun; 156():104798. PubMed ID: 32278045
[TBL] [Abstract][Full Text] [Related]
17. mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A.
Harwood FC; Shu L; Houghton PJ
J Biol Chem; 2008 Feb; 283(5):2575-85. PubMed ID: 18056704
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
19. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
[TBL] [Abstract][Full Text] [Related]
20. The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-mTORC1 axis.
Krishan S; Sahni S; Richardson DR
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165970. PubMed ID: 32950675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]